bromodeoxyuridine has been researched along with Nervous System Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askew, KE; Fryatt, GL; Gomez-Nicola, D | 1 |
| Chen, ZY; Dong, L; Jing, FM; Kong, L; Liu, JX; Shang, ZH; Sun, T; Wang, XJ; Xin, H; Xu, XF; Yang, KQ; Zhang, QY | 1 |
| Schnell, E; Villasana, LE; Westbrook, GL | 1 |
| Chen, J; Gao, Y; Hu, X; Leak, RK; Shi, Y; Wang, H; Zhang, H; Zhang, W | 1 |
| Chang, L; Feng, GF; Qian, YH; Shi, QD; Yang, J; Yang, YB; Zong, CH | 1 |
| Cao, Y; Feng, L; Han, Z; Hou, ST; Liu, S; Qu, M; Xiao, M; Ye, Z; Zhang, Z; Zheng, R | 1 |
| Gu, X; Li, J; Wang, LL; Wei, L; Yu, SP | 1 |
| Cai, Y; Huang, L; Liu, F; Sun, C; Wang, C; You, Y; Zhang, M | 1 |
| Galán, RF; Karlo, JC; Landreth, GE; Pucilowska, J; Puzerey, PA | 1 |
| Fazel, A; Hamidi Alamdari, D; Hosseini, M; Jalali, M; Nikravesh, MR; Seghatoleslam, M | 1 |
| Date, I; Kago, T; Matsumoto, K; Nakamura, T; Takagi, K; Takagi, N; Takeo, S | 1 |
| Arthur-Farraj, P; Jessen, KR; Mirsky, R; Parkinson, DB | 1 |
| Cai, G; Chen, X; Liu, B; Liu, W; Rong, J; Shen, J; Tan, X; Tong, L | 1 |
| Greinert, U; Müller-Quernheim, J; Schlaak, M; Schreiber, J; Zissel, G | 1 |
| Elizan, TS; Schwartz, J | 1 |
15 other study(ies) available for bromodeoxyuridine and Nervous System Disorders
| Article | Year |
|---|---|
Measuring Microglial Turnover in the Adult Brain.
Topics: Aging; Animals; Brain; Bromodeoxyuridine; Immunohistochemistry; Mice; Mice, Transgenic; Microglia; Nervous System Diseases; Staining and Labeling | 2019 |
Gypenosides pre-treatment protects the brain against cerebral ischemia and increases neural stem cells/progenitors in the subventricular zone.
Topics: Analysis of Variance; Animals; Brain Infarction; Brain Ischemia; Bromodeoxyuridine; Cerebral Ventricles; Disease Models, Animal; Dose-Response Relationship, Drug; Doublecortin Protein; Gynostemma; Male; Nerve Tissue Proteins; Nervous System Diseases; Neural Stem Cells; Neuroprotective Agents; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley | 2014 |
Neurologic impairment following closed head injury predicts post-traumatic neurogenesis.
Topics: Animals; Bromodeoxyuridine; Dentate Gyrus; Disease Models, Animal; Doublecortin Domain Proteins; Female; Galectin 3; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Green Fluorescent Proteins; Head Injuries, Closed; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microtubule-Associated Proteins; Nervous System Diseases; Neurogenesis; Neuropeptides; Pro-Opiomelanocortin; Proto-Oncogene Proteins c-fos | 2014 |
Dietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke.
Topics: Analysis of Variance; Animals; Bromodeoxyuridine; Cell Proliferation; Cerebrovascular Circulation; Dietary Supplements; Disease Models, Animal; Doublecortin Domain Proteins; Fatty Acids; Fatty Acids, Omega-3; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Motor Activity; Nervous System Diseases; Neurogenesis; Neuropeptides; Phosphopyruvate Hydratase; Psychomotor Performance; Time Factors | 2015 |
Vasoactive intestinal peptide administration after stroke in rats enhances neurogenesis and improves neurological function.
Topics: Animals; Antigens, CD34; Bromodeoxyuridine; Cell Count; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Endothelial Cells; Infarction, Middle Cerebral Artery; Male; Microtubule-Associated Proteins; Nervous System Diseases; Neurogenesis; Neuropeptides; Rats; Rats, Sprague-Dawley; Time Factors; Vascular Endothelial Growth Factor A; Vasoactive Intestinal Peptide | 2015 |
Curcumin protects against stroke and increases levels of Notch intracellular domain.
Topics: Analysis of Variance; Animals; Brain; Bromodeoxyuridine; Cell Count; Cerebral Ventricles; Curcumin; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Male; Microtubule-Associated Proteins; Nervous System Diseases; Neurogenesis; Neurologic Examination; Neuropeptides; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Notch; Signal Transduction; Stroke; Time Factors | 2016 |
Delayed treatment of 6-Bromoindirubin-3'-oxime stimulates neurogenesis and functional recovery after focal ischemic stroke in mice.
Topics: Animals; Brain Ischemia; Bromodeoxyuridine; Cell Count; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; Indoles; Lateral Ventricles; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Nervous System Diseases; Neurogenesis; Neuropeptides; Oximes; Phosphopyruvate Hydratase; Psychomotor Performance; Reaction Time; Recovery of Function; Signal Transduction; Stroke; Time Factors | 2017 |
Sustained increase in adult neurogenesis in the rat hippocampal dentate gyrus after transient brain ischemia.
Topics: Adult Stem Cells; Animals; Brain Ischemia; Bromodeoxyuridine; Cell Count; Dentate Gyrus; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Functional Laterality; Ki-67 Antigen; Male; Microtubule-Associated Proteins; Nervous System Diseases; Neurogenesis; Neuropeptides; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Time Factors | 2011 |
Disrupted ERK signaling during cortical development leads to abnormal progenitor proliferation, neuronal and network excitability and behavior, modeling human neuro-cardio-facial-cutaneous and related syndromes.
Topics: Animals; Antimetabolites; Anxiety; Behavior, Animal; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cerebral Cortex; Cognition Disorders; Conditioning, Operant; Extracellular Signal-Regulated MAP Kinases; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Net; Nervous System Diseases; Neurons; Patch-Clamp Techniques; Signal Transduction; Stem Cells | 2012 |
Intravenous administration of human umbilical cord blood-mononuclear cells dose-dependently relieve neurologic deficits in rat intracerebral hemorrhage model.
Topics: Animals; Antimetabolites; Behavior, Animal; Brain; Bromodeoxyuridine; Cell Movement; Cell Separation; Cell Survival; Centrifugation, Density Gradient; Cord Blood Stem Cell Transplantation; Flow Cytometry; Humans; Immunohistochemistry; Intracranial Hemorrhages; Leukocyte Common Antigens; Male; Monocytes; Nervous System Diseases; Rats; Rats, Wistar; Recovery of Function; Stroke | 2013 |
Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats.
Topics: Analysis of Variance; Animals; Apoptosis; Behavior, Animal; Blood Vessels; Blotting, Western; Brain; Bromodeoxyuridine; Cell Count; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Functional Laterality; Hepatocyte Growth Factor; Humans; In Situ Nick-End Labeling; Intracranial Embolism; Learning; Male; Maze Learning; Memory Disorders; Microspheres; Nervous System Diseases; Neurologic Examination; Proto-Oncogene Proteins c-met; Rats; Rats, Wistar; Recombinant Proteins; Staining and Labeling; Time Factors | 2004 |
A double point mutation in the DNA-binding region of Egr2 switches its function from inhibition to induction of proliferation: A potential contribution to the development of congenital hypomyelinating neuropathy.
Topics: Alleles; Animals; Antimetabolites; Blotting, Western; Bromodeoxyuridine; Cell Death; Cell Proliferation; Cell Survival; DNA; Early Growth Response Protein 2; Immunohistochemistry; Membrane Proteins; Myelin P0 Protein; Myelin Sheath; Neoplasm Proteins; Nervous System Diseases; Neuregulin-1; Point Mutation; Proto-Oncogene Proteins c-jun; Rats; Repressor Proteins; Schwann Cells; Signal Transduction; Transforming Growth Factor beta | 2006 |
Buyang Huanwu Decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains.
Topics: Animals; Brain; Brain Ischemia; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Drugs, Chinese Herbal; Immunohistochemistry; Male; Nerve Growth Factors; Nervous System Diseases; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Stem Cells; Time Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
Topics: Adult; Anaphylaxis; Anti-Bacterial Agents; Antitubercular Agents; Bromodeoxyuridine; Cells, Cultured; Chemical and Drug Induced Liver Injury; DNA Replication; Drug Eruptions; Drug Hypersensitivity; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Isoniazid; Kidney Diseases; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nervous System Diseases; Rifampin; Tuberculosis | 1999 |
Further characterization of suckling mouse cataract agent (SMCA): a slow, persistent infection of the nervous system.
Topics: Animals; Arboviruses; Bromodeoxyuridine; Cataract; Chick Embryo; Dactinomycin; Filtration; Hot Temperature; Hydrogen-Ion Concentration; Hydroxyurea; Inclusion Bodies, Viral; Kanamycin; Lens, Crystalline; Mice; Micropore Filters; Microscopy, Electron; Nervous System Diseases; Organ Culture Techniques; Particle Size; Penicillin Resistance; Penicillins; Rabbits; Rifampin; Slow Virus Diseases; Streptomycin; Trypsin; Ultraviolet Rays; Virus Replication | 1972 |